New mouth gel for seizures under safety watch in japan
NCT ID NCT05313308
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tracks 50 people in Japan who receive a midazolam mouth solution for status epilepticus (a long-lasting seizure). Doctors will record side effects over 6 months and check if the drug stops seizures within 10 minutes. The sponsor does not control treatment; clinics follow their usual practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinigen selected site
RECRUITINGTokyo, Japan
Conditions
Explore the condition pages connected to this study.